pharmaceutical-investing Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
pharmaceutical-investing Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura
pharmaceutical-investing Stellar Biotechnologies enters exclusive agreement with Amaran Biotechnology
LAURION Reports Wide Mineralized Zones and High-Grade Polymetallic Intercepts from LBX25-097 and LBX25-100, Advancing Structural Continuity at Ishkoday
